InflaRx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
IFRX Key Statistics
Stock Snapshot
With a market cap of 84.59M, InflaRx(IFRX) trades at $1.26. The stock has a price-to-earnings ratio of -1.18.
During the trading session on 2025-11-18, InflaRx(IFRX) shares reached a daily high of $1.40 and a low of $1.24. At a current price of $1.26, the stock is +1.6% higher than the low and still -10.0% under the high.
Trading volume for InflaRx(IFRX) stock has reached 1.67M, versus its average volume of 14.38M.
Over the past 52 weeks, InflaRx(IFRX) stock has traded between a high of $2.82 and a low of $0.71.
Over the past 52 weeks, InflaRx(IFRX) stock has traded between a high of $2.82 and a low of $0.71.
IFRX News
LifeSci Capital analyst Sam Slutsky has maintained their neutral stance on IFRX stock, giving a Hold rating yesterday. Meet Your ETF AI Analyst Discover how Tip...
Raymond James analyst Ryan Deschner raised the firm’s price target on InflaRx (IFRX) to $9 from $2 and keeps an Outperform rating on the shares. Inflarx reporte...